Hostname: page-component-7479d7b7d-rvbq7 Total loading time: 0 Render date: 2024-07-13T17:04:49.832Z Has data issue: false hasContentIssue false
  • English
  • Français

Seroprevalence of Antibodies to Hepatitis C Virus in High-Risk Hospital Personnel

Published online by Cambridge University Press:  21 June 2016

Brian W. Cooper ,
Allan Krusell ,
Richard C. Tilton ,
Randolph Goodwin  and
Robert E. Levitz
Brian W. Cooper*
Affiliation:
Division of Infectious Diseases, Hartford Hospital, Hartford, The University of Connecticut Medical School, Farmington
Allan Krusell
Affiliation:
Division of Infectious Diseases, Hartford Hospital, Hartford, The University of Connecticut Medical School, Farmington
Richard C. Tilton
Affiliation:
North American Laboratory Group, New Britain, Connecticut
Randolph Goodwin
Affiliation:
Division of Infectious Diseases, Hartford Hospital, Hartford, The University of Connecticut Medical School, Farmington
Robert E. Levitz
Affiliation:
Division of Infectious Diseases, Hartford Hospital, Hartford, The University of Connecticut Medical School, Farmington
*
Division of Infectious Diseases, Hartford Hospital, Hartford, CT 06115
Get access Rights & Permissions [Opens in a new window]

Abstract

Obective:

To estimate seroprevalence of antibodies to hepatitis C virus in healthcare workers at high risk for blood exposure.

Design:

A prospective anonymous seroprevalence survey of 243 healthcare workers.

setting:

A large referral hospital and 2 community hospitals in Connecticut.

Participants:

Healthcare workers, including surgical personnel, dentists, hemodialysis workers, laboratory workers, and emergency room staff.

Results:

Antibody to hepatitis C virus was found in 1.6% (95% confidence interval [CI95] = 03.2%) of healthcare workers. None of the prevalent seropositives had a past history of clinical hepatitis or blood transfusion.

Conclusions:

We conclude that the sero-prevalence of hepatitis C virus in healthcare workers with a high degree of blood exposure is low and is similar to seroprevalence rates reported for volunteer blood donors. However, first-generation hepatitis C serologic tests may underestimate the true prevalence of infection. Further studies, including prospective cohort studies, will be required to determine if the low seroprevalence is from low risk of acquisition of disease or from loss of measurable humoral antibody response to the virus.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 2 , February 1992 , pp. 82 - 85
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kuo, G, Choo, Q-L, Alter, HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362–364.CrossRefGoogle ScholarPubMed
2. Van der Poel, CL, Reesink, HW, Lelie, PN. et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet. 1989;ii:297–298.CrossRefGoogle Scholar
3. Stevens, CE, Taylor, PE, Pindyck, J, et al. Epidemiology of hepatitis C virus, a preliminary study in volunteer blood donors. JAMA. 1990:263:49–53.CrossRefGoogle ScholarPubMed
4. Lewis, TL, Alter, HJ, Chalmers, TC, et al. A comparison of the frequency of hepatitis B antigen and antibody in hospital and nonhospital personnel. N Engl J Med. 1973;289:647–651.CrossRefGoogle ScholarPubMed
5. Kiyosawa, K, Sodeyama, T, Tanaka, E, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med. 1991;115:367–369.CrossRefGoogle ScholarPubMed
6. Seeff, LB. Hepatitis C from a needlestick injury. Ann Intern Med. 1991;115–411.Google ScholarPubMed
7. Jovanovich, JF, Saravolatz, LD, Arking, LM. The risk of hepatitis B among select employee groups in an urban hospital. JAMA. 1983;250:1893–1894.CrossRefGoogle Scholar
8. Hofmann, H, Kunz, C. Low risk of healthcare workers for infection with hepatitis C virus. Infection. 1990;18:286–288.CrossRefGoogle ScholarPubMed
9. Polywaka, S, Laufs, R. Hepatitis C virus antibodies among different groups at risk and patients with suspected non-A, non-B hepatitis. Infection. 1991;19:27–30.Google Scholar
10. Alter, HJ, Purcell, RH, Shih, JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989;321:1494–1500.CrossRefGoogle ScholarPubMed
11. Niu, MT, Alter, M, Kristensen, C, Hadler, SC. Hepatitis C virus outbreak in a hemodialysis unit. Presented at the 3rd International Conference on Nosocomial Infections. July 31-August 2, 1990. Atlanta, Ga. Abstract #B/62.Google Scholar
12. Wormser, GP, Forseter, G, Joliene, C, Tupper, B, O’Brien, TA. Low risk of hepatitis C infection following parenteral exposure to blood of HIV-infected patients. Am J Infect Control. 1991;19:110.CrossRefGoogle Scholar
13. Yoshizawa, H, Itoh, Y, Iwakiri, S, et al. Non-A, non-B (type 1) hepatitis agent capable of inducing tubular structures in the hepatocyte cytoplasm of chimpanzees in activation by formulin and heat. Gastroenterology. 1982;82:502–506.CrossRefGoogle Scholar